Open Access
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2017; 38(01): 84-87
DOI: 10.4103/0971-5851.203491
Practitioner Section

Primitive Neuroectodermal Tumor of Lung in Adult with Hemorrhagic Brain Metastasis: An Extremely Rare Case Scenario

Abhishek Purkayastha
Department of Radiation Oncology, Army Hospital (Research and Referral), New Delhi, India
,
Neelam Sharma
Department of Radiation Oncology, Army Hospital (Research and Referral), New Delhi, India
,
Amul Kapur
Department of Medical Oncology, Army Hospital (Research and Referral), New Delhi, India
,
Kavita Sahai
Department of Pathology and Molecular Science, Army Hospital (Research and Referral), New Delhi, India
› Institutsangaben

Financial support and sponsorship Nil.
Preview

Abstract

Primitive neuroectodermal tumors (PNETs) are highly malignant neoplasms of embryonal origin manifesting in children and adolescents, rarely seen in adults. Carcinoma lung with hemorrhagic metastasis to the brain is very common, but primary lung PNET with hemorrhagic brain metastasis is extremely uncommon. We hereby report a 29-year-old female diagnosed as PNET lung was treated with vincristine, adriamycin, and cyclophosphamide alternating with ifosfamide plus etoposide followed by radiotherapy (RT). After 9 months, she developed hemorrhagic brain metastasis from PNET lung confirmed from tissue immunohistology postcraniotomy. Received palliative whole brain RT followed by oral pazopanib resulting in significant improvement in performance status. A thorough review of literature reveals that our case may be the second case of primary lung PNET with hemorrhagic brain metastasis and also thefirst to be exhibited oral pazopanib resulting in a significant therapeutic effect to be reported in world literature till date.



Publikationsverlauf

Artikel online veröffentlicht:
06. Juli 2021

© 2017. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Windfuhr JP. Primitive neuroectodermal tumor of the head and neck: Incidence, diagnosis, and management. Ann Otol Rhinol Laryngol 2004;113:533-43.
  • 2 Javery O, Krajewski K, O'Regan K, Kis B, Giardino A, Jagannathan J, et al. Ato Z of extraskeletal Ewing sarcoma family of tumors in adults: Imaging features of primary disease, metastatic patterns, and treatment responses. AJR Am J Roentgenol 2011;197:W1015-22.
  • 3 Huh J, Kim KW, Park SJ, Kim HJ, Lee JS, Ha HK, et al. Imaging features of primary tumors and metastatic patterns of the extraskeletal Ewing sarcoma family of tumors in adults: A 17-year experience at a single institution. Korean J Radiol 2015;16:783-90.
  • 4 Shi L, Guo Z, Wu X. Primary pulmonary primitive neuroectodermal tumor metastasis to the pancreas: A rare case with seven-year follow-up. Diagn Pathol 2013;8:51.
  • 5 Somers GR, Shago M, Zielenska M, Chan HS, Ngan BY. Primary subcutaneous primitive neuroectodermal tumor with aggressive behavior and an unusual karyotype: Case report. Pediatr Dev Pathol 2004;7:538-45.
  • 6 Armbruster C, Huber M, Prosch H, Dworan N, Attems J. Ewing's sarcoma and peripheral primitive neuroectodermal tumor in adults: Different features of a rare neoplasm. Onkologie 2008;31:179-84.
  • 7 Mandava V, Sreedhar B, Pasam RK, Bala GS. Primary pulmonary primitive neuroectodermal tumor with CNS metastasis. JCR 2014;4:508-11.
  • 8 Carvajal R, Meyers P. Ewing's sarcoma and primitive neuroectodermal family of tumors. Hematol Oncol Clin North Am 2005;19:501-25, vi-vii.
  • 9 van der Graaf WT, Blay JY, Chawla SP, Kim DW, Bui-Nguyen B, Casali PG, et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2012;379:1879-86.
  • 10 Attia S, Okuno SH, Robinson SI, Webber NP, Indelicato DJ, Jones RL, et al. Clinical activity of pazopanib in metastatic extraosseous Ewing sarcoma. Rare Tumors 2015;7:5992.